Variation in the Diagnosis, Treatment, and Management of Melanoma In Situ

Charles, Carlos A.; Yee, Vivian S. K.; Dusza, Stephen W.; Marghoob, Ashfaq A.; Oliveria, Susan A.; Kopf, Alfred W.; Rigel, Darrell S.; Halpern, Allan C.

doi:10.1001/archderm.141.6.723

Cited by 47 publications

(30 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In contrast, despite the above considerations, CMIS is linked to some health concerns and unsolved debates regarding its clinicopathologic diagnosis [19 -24], therapeutic/follow-up management [20,[25][26][27][28][29], and prognostic relevance [24, 30 -32].…”

Section: Introductionmentioning

confidence: 99%

Cutaneous Melanoma In Situ: Translational Evidence from a Large Population-Based Study

Mocellin

Nitti

2011

The Oncologist

View full text Add to dashboard Cite

Background. Cutaneous melanoma in situ (CMIS) is a nosologic entity surrounded by health concerns and unsolved debates. We aimed to shed some light on CMIS by means of a large population-based study. Methods. Patients with histologic diagnosis of CMIS were identified from the Surveillance Epidemiology End Results (SEER) database.Results. The records of 93,863 cases of CMIS were available for analysis. CMIS incidence has been steadily increasing over the past 3 decades at a rate higher than any other in situ or invasive tumor, including invasive skin melanoma (annual percentage change [APC]: 9.5% versus 3.6%, respectively). Despite its noninvasive nature, CMIS is treated with excision margins wider than 1 cm in more than one third of cases. CMIS is associated with an increased risk of invasive melanoma (standardized incidence ratio [SIR]: 8.08; 95% confi-

show abstract

Section: Introductionmentioning

confidence: 99%

Cutaneous Melanoma In Situ: Translational Evidence from a Large Population-Based Study

Mocellin

Nitti

2011

The Oncologist

View full text Add to dashboard Cite

show abstract

“…20 In 2005, a small pilot survey of 597 US dermatologists found that 17.4% of respondents used dermatoscopy. 21 Dermatoscopy use during residency was evaluated by a survey of 83 US dermatology residency program directors in 2002; 51% of the programs reported using dermatoscopy in the evaluation of pigmented lesions. 22 Although these small studies suggest relatively low usage rates, to date, comprehensive information on the prevalence of dermatoscope use by practicing US dermatologists has been lacking.…”

mentioning

confidence: 99%

Dermatoscopy use by US dermatologists: A cross-sectional survey

Engasser¹,

Warshaw²

2010

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…In a survey of the practices of dermatoscopy among US dermatologists in 2001, 17% of responding dermatologists from the American Board of Medical Specialists Directory of Board Certified Medical Specialists reported using dermatoscopy to aid in clinical assessment, compared with 57% using a magnifying lens. 9 Since then, dermatoscopy practices have increased significantly, ranging from 51% of respondents in a survey of academic dermatology training programs to 70% of survey respondents attending a dermatoscopy seminar at the American Academy of Dermatology's Summer Academy meeting in 2007. The most common reported reasons for using dermatoscopy across survey studies was the belief that it aided in the early detection of melanoma, led to fewer biopsies, and reduced patient anxiety.…”

Section: History Of Dermatoscopy and Its Usesmentioning

confidence: 99%